Evolent Health (EVH) Acquisitions (2015 - 2025)

Evolent Health's Acquisitions history runs 11 years deep, the most recent figure standing at $1.4 million for Q4 2025.

• On a quarterly basis, Acquisitions fell 89.85% year-over-year to $1.4 million in Q4 2025; TTM through Mar 2026 was $52.9 million, a 56.47% increase from a year earlier, with the FY2025 full-year figure at $57.4 million, up 86.96% from the prior year.
• Acquisitions advanced to $1.4 million in Q4 2025 per EVH's latest filing, from -$2000.0 in the prior quarter.
• Across five years, Acquisitions topped out at $386.7 million in Q1 2023 and bottomed at -$2000.0 in Q3 2025.
• The 5-year median for Acquisitions is $4.5 million (2025), against an average of $45.5 million.
• Across the five-year window, Acquisitions soared 552362.86% in 2023 and tumbled 100.02% in 2025, its largest moves.
• Year by year, Acquisitions stood at $47.1 million in 2021, then slumped by 93.44% to $3.1 million in 2022, then tumbled by 50.74% to $1.5 million in 2023, then jumped by 805.26% to $13.8 million in 2024, then plunged by 89.85% to $1.4 million in 2025.
• Per Business Quant, the three latest EVH Acquisitions figures stand at $1.4 million (Q4 2025), -$2000.0 (Q3 2025), and $51.5 million (Q2 2025).